GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Peter Lynch Fair Value

Eurofins Scientific SE (Eurofins Scientific SE) Peter Lynch Fair Value : $34.23 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Eurofins Scientific SE's PEG is 1. Eurofins Scientific SE's 5-Year TTM EBITDA Growth Rate is 11.89. Eurofins Scientific SE's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $2.88. Therefore, the Peter Lynch Fair Value for today is $34.23.

As of today (2024-04-27), Eurofins Scientific SE's share price is $60.00. Eurofins Scientific SE's Peter Lynch fair value is $34.23. Therefore, Eurofins Scientific SE's Price to Peter Lynch Fair Value Ratio for today is 1.75.


The historical rank and industry rank for Eurofins Scientific SE's Peter Lynch Fair Value or its related term are showing as below:

ERFSF' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.67   Med: 1.12   Max: 1.8
Current: 1.58


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Eurofins Scientific SE was 1.80. The lowest was 0.67. And the median was 1.12.


ERFSF's Price-to-Peter-Lynch-Fair-Value is ranked better than
50% of 50 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.625 vs ERFSF: 1.58

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Eurofins Scientific SE Peter Lynch Fair Value Historical Data

The historical data trend for Eurofins Scientific SE's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Peter Lynch Fair Value Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.79 103.56 147.09 88.00 38.17

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 147.09 - 88.00 - 38.17

Competitive Comparison of Eurofins Scientific SE's Peter Lynch Fair Value

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Price-to-Peter-Lynch-Fair-Value falls into.



Eurofins Scientific SE Peter Lynch Fair Value Calculation

Eurofins Scientific SE's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 11.89 *2.879
=34.23

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $2.88.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Eurofins Scientific SE  (OTCPK:ERFSF) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 11.89 instead of 15 in this case.

Eurofins Scientific SE's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=60.00/34.23
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (Eurofins Scientific SE) Headlines